These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228 [TBL] [Abstract][Full Text] [Related]
11. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits. Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301 [TBL] [Abstract][Full Text] [Related]
12. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Anzai Y; Piccoli CW; Outwater EK; Stanford W; Bluemke DA; Nurenberg P; Saini S; Maravilla KR; Feldman DE; Schmiedl UP; Brunberg JA; Francis IR; Harms SE; Som PM; Tempany CM; Radiology; 2003 Sep; 228(3):777-88. PubMed ID: 12954896 [TBL] [Abstract][Full Text] [Related]
14. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. Nishimura H; Tanigawa N; Hiramatsu M; Tatsumi Y; Matsuki M; Narabayashi I J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430 [TBL] [Abstract][Full Text] [Related]
15. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results. Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053 [TBL] [Abstract][Full Text] [Related]
17. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics. Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219 [TBL] [Abstract][Full Text] [Related]
18. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model. Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719 [TBL] [Abstract][Full Text] [Related]
19. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging. Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369 [TBL] [Abstract][Full Text] [Related]
20. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma. Nguyen BC; Stanford W; Thompson BH; Rossi NP; Kernstine KH; Kern JA; Robinson RA; Amorosa JK; Mammone JF; Outwater EK J Magn Reson Imaging; 1999 Sep; 10(3):468-73. PubMed ID: 10508310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]